Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 107805, 8 pages
http://dx.doi.org/10.1155/2013/107805
Research Article

Short-Term Exercise Training Improves Insulin Sensitivity but Does Not Inhibit Inflammatory Pathways in Immune Cells from Insulin-Resistant Subjects

1Medical Research Division, Regional Academic Health Center, 1214 W. Schunior Street, Edinburg, TX 78541, USA
2Diabetes Division, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
3Texas Diabetes Institute, 701 S. Zarzamora, San Antonio, TX 78207, USA
4Geriatric, Research, Education, and Clinical Center, Audie L. Murphy VA Hospital, 7400 Merton Minter Boulevard, San Antonio, TX 78229, USA

Received 2 November 2012; Accepted 16 January 2013

Academic Editor: Raffaele Marfella

Copyright © 2013 Sara M. Reyna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. K. Pedersen, “The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control,” Essays in Biochemistry, vol. 42, pp. 105–117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. E. Duncan, M. G. Perri, D. W. Theriaque, A. D. Hutson, R. H. Eckel, and P. W. Stacpoole, “Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults,” Diabetes Care, vol. 26, no. 3, pp. 557–562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Green, A. Maiorana, G. O'Driscoll, and R. Taylor, “Effect of exercise training on endothelium-derived nitric oxide function in humans,” Journal of Physiology, vol. 561, no. 1, pp. 1–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Simpson, B. K. McFarlin, C. McSporran, G. Spielmann, B. O. Hartaigh, and K. Guy, “Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans,” Brain, Behavior, and Immunity, vol. 23, no. 2, pp. 232–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Steensberg, A. D. Toft, H. Bruunsgaard, M. Sandmand, J. Halkjær-Kristensen, and B. K. Pedersen, “Strenuous exercise decreases the percentage of type 1 T cells in the circulation,” Journal of Applied Physiology, vol. 91, no. 4, pp. 1708–1712, 2001. View at Google Scholar · View at Scopus
  6. J. A. Smith, A. B. Gray, D. B. Pyne, M. S. Baker, R. D. Telford, and M. J. Weidemann, “Moderate exercise triggers both priming and activation of neutrophil subpopulations,” American Journal of Physiology, vol. 270, no. 4, pp. R838–R845, 1996. View at Google Scholar · View at Scopus
  7. S. Balducci, S. Zanuso, A. Nicolucci et al., “Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 8, pp. 608–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Hevener, J. M. Olefsky, D. Reichart et al., “Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones,” Journal of Clinical Investigation, vol. 117, no. 6, pp. 1658–1669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Feuerer, L. Herrero, D. Cipolletta et al., “Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters,” Nature Medicine, vol. 15, no. 8, pp. 930–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Calles-Escandon and M. Cipolla, “Diabetes and endothelial dysfunction: a clinical perspective,” Endocrine Reviews, vol. 22, no. 1, pp. 36–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. V. Bobryshev, “Monocyte recruitment and foam cell formation in atherosclerosis,” Micron, vol. 37, no. 3, pp. 208–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Reyna, S. Ghosh, P. Tantiwong et al., “Elevated Toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects,” Diabetes, vol. 57, no. 10, pp. 2595–2602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Caricilli, P. H. Nascimento, J. R. Pauli et al., “Inhibition of Toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet,” Journal of Endocrinology, vol. 199, no. 3, pp. 399–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. Mullick, P. S. Tobias, and L. K. Curtiss, “Toll-like receptors and atherosclerosis: key contributors in disease and health?” Immunologic Research, vol. 34, no. 3, pp. 193–209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Dasu, S. Devaraj, S. Park, and I. Jialal, “Increased Toll-Like Receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects,” Diabetes Care, vol. 33, no. 4, pp. 861–868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Hasu, M. Thabet, N. Tam, and S. C. Whitman, “Specific loss of Toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice,” Canadian Journal of Physiology and Pharmacology, vol. 89, no. 10, pp. 737–742, 2011. View at Publisher · View at Google Scholar
  19. K. S. Michelsen, M. H. Wong, P. K. Shah et al., “Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10679–10684, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. B. K. McFarlin, M. G. Flynn, W. W. Campbell, L. K. Stewart, and K. L. Timmerman, “TLR4 is lower in resistance-trained older women and related to inflammatory cytokines,” Medicine and Science in Sports and Exercise, vol. 36, no. 11, pp. 1876–1883, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. K. Stewart, M. G. Flynn, W. W. Campbell et al., “Influence of exercise training and age on CD14+ cell-surface expression of Toll-like receptor 2 and 4,” Brain, Behavior, and Immunity, vol. 19, no. 5, pp. 389–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. T. A. Nguyen, S. Favelyukis, A. K. Nguyen et al., “A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways,” Journal of Biological Chemistry, vol. 282, no. 48, pp. 35279–35292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Varma, A. Yao-Borengasser, N. Rasouli et al., “Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 6, pp. E1300–E1310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. R. Karlmark, H. E. Wasmuth, C. Trautwein, and F. Tacke, “Chemokine-directed immune cell infiltration in acute and chronic liver disease,” Expert Review of Gastroenterology and Hepatology, vol. 2, no. 2, pp. 233–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Sriwijitkamol, D. K. Coletta, E. Wajcberg et al., “Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study,” Diabetes, vol. 56, no. 3, pp. 836–848, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” The American Journal of Physiology, vol. 237, no. 3, pp. E214–E223, 1979. View at Google Scholar · View at Scopus
  27. C. Frøsig, M. P. Sajan, S. J. Maarbjerg et al., “Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle,” Journal of Physiology, vol. 582, no. 3, pp. 1289–1301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Bouzakri, H. K. R. Karlsson, H. Vestergaard, S. Madsbad, E. Christiansen, and J. R. Zierath, “IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients,” Diabetes, vol. 55, no. 3, pp. 785–791, 2006. View at Google Scholar · View at Scopus
  29. D. Cipolletta, M. Feuerer, A. Li et al., “PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells,” Nature, vol. 486, pp. 549–553, 2012. View at Google Scholar
  30. M. Oliveira and M. Gleeson, “The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men,” European Journal of Applied Physiology, vol. 109, no. 2, pp. 251–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. K. L. Timmerman, M. G. Flynn, P. M. Coen, M. M. Markofski, and B. D. Pence, “Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?” Journal of Leukocyte Biology, vol. 84, no. 5, pp. 1271–1278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Häkkinen, K. Karkola, and S. Ylä-Herttuala, “Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions: colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (FcγRIII),” Virchows Archiv, vol. 437, no. 4, pp. 396–405, 2000. View at Google Scholar · View at Scopus
  33. S. Devaraj, M. R. Dasu, J. Rockwood, W. Winter, S. C. Griffen, and I. Jialal, “Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 2, pp. 578–583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Saberi, N. B. Woods, C. de Luca et al., “Hematopoietic cell-specific deletion of Toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice,” Cell Metabolism, vol. 10, no. 5, pp. 419–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Jager, V. Corcelle, T. Grémeaux et al., “Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity,” Diabetologia, vol. 54, no. 1, pp. 180–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Yao, W. Li, J. Wu et al., “Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 22, pp. 12759–12764, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyörälä, and M. Laakso, “Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,” New England Journal of Medicine, vol. 339, no. 4, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. K. R. Coenen, M. L. Gruen, R. S. Lee-Young, M. J. Puglisi, D. H. Wasserman, and A. H. Hasty, “Impact of macrophage Toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice,” Diabetologia, vol. 52, no. 2, pp. 318–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Hu, L. C. Moscinski, N. I. Valkov, A. B. Fisher, B. J. Hill, and K. S. Zuckerman, “Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line,” Cell Growth and Differentiation, vol. 11, no. 4, pp. 191–200, 2000. View at Google Scholar · View at Scopus
  40. N. Ashida, H. Arai, M. Yamasaki, and T. Kita, “Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis,” Journal of Biological Chemistry, vol. 276, no. 19, pp. 16555–16560, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Wang, D. Li, K. Yang, Y. Hu, and Q. Zeng, “Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome,” Immunology, vol. 125, no. 1, pp. 122–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Esposito, C. Perrino, G. G. Schiattarella et al., “Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload,” Hypertension, vol. 55, no. 1, pp. 137–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. E. D. Boehmer, J. Goral, D. E. Faunce, and E. J. Kovacs, “Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 342–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Renshaw, J. Rockwell, C. Engleman, A. Gewirtz, J. Katz, and S. Sambhara, “Cutting edge: impaired Toll-like receptor expression and function in aging,” Journal of Immunology, vol. 169, no. 9, pp. 4697–4701, 2002. View at Google Scholar · View at Scopus
  45. J. Hirosumi, G. Tuncman, L. Chang et al., “A central, role for JNK in obesity and insulin resistance,” Nature, vol. 420, no. 6913, pp. 333–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. K. C. Sourris, J. G. Lyons, M. P. J. de Courten et al., “c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-κB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals,” Diabetes, vol. 58, no. 6, pp. 1259–1265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Blüher, N. Bashan, I. Shai et al., “Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body insulin sensitivity,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 7, pp. 2507–2515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Boden, X. Duan, C. Homko et al., “Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals,” Diabetes, vol. 57, no. 9, pp. 2438–2444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Patel, H. Ghanim, S. Ravishankar et al., “Prolonged reactive oxygen species generation and nuclear factor-κB activation after a high-fat, high-carbohydrate meal in the obese,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4476–4479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Ghanim, A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty, and P. Dandona, “Circulating mononuclear cells in the obese are in a proinflammatory state,” Circulation, vol. 110, no. 12, pp. 1564–1571, 2004. View at Publisher · View at Google Scholar · View at Scopus